Abstract:Pulmonary lymphoepithelioma-like carcinoma (LELC) is a rare and distinct type of primary lung cancer which is characterized by Epstein-Barr virus (EBV) infection. Only a few hundred cases have been reported since its discovery in 1987. Due to its extreme rareness, its genomic landscape remains elusive. In this study, we performed targeted ultra-deep sequencing to interrogate the genomic profile and tumor mutation burden of 10 patients with pulmonary LELC. Ten patients with advanced pulmonary LELC patients were enrolled. Tissue biopsy samples were subjected to targeted sequencing with an average sequencing depth of 1,000x, using a panel consisting of 295 cancer-related genes, spanning 2.02Mb of human genome. TMB was calculated as the ratio of number of mutations to the size of coding region of the panel, excluding copy number variations, fusions and large genomic rearrangements. We enrolled 10 patients (4 males and 6 females) with advanced pulmonary LELC and a median age of 60. Eight of them are non-smokers and 2 are smokers. Collectively, we identified 65 somatic mutations spanning 52 genes, including 33 SNVs, 3 insertions or deletions (INDELs) and 29 copy-number amplifications (CNAs). No mutation in classic NSCLC driver gene was identified, in an agreement of published data. The most frequently mutated genes were TP53, FGFR3, FGFR4, FGFR19 and CCND1, occurring in 30% (3/10) patients followed by KIT and KMT2D, occurring in 20% (2/10) patients. Interestingly, 7 patients had mutations in epigenetic regulators, such as DNA methyltransferase and chromatin remodelers. Pathway analysis also revealed an enrichment of genes participating in chromatin remodeling and organization. Next, we compared the genomic profile of pulmonary LELC with nasopharyngeal carcinoma and EBV positive gastric cancer mutation profiles obtained from TCGA, and revealed similarity with both of them. Patients in this cohort had a median TMB of 3.75/Mb (ranged from 1.25/Mb to 10/Mb), which is significantly lowered than lung adenocarcinomas. All patients had PD-L1 overexpression; 4 of them with PD-L1 expression in greater than 50% of tumor cells and the remaining 6 patients had PD-L1 expression between 5%-49% of tumor cells. In this study, we elucidated a distinct genomic landscape associated with pulmonary LELC with no classic NSCLC driver mutation but an enrichment of mutations in epigenetic regulators. The observation of high expression of PD-L1 and lack of canonical druggable driver mutation raises the potential of immunocheckpoint blockade therapy for LELC.

Eber- and LMP-1-expressing pulmonary lymphoepithelioma-like carcinoma in a Caucasian patient

Epstein-Barr Virus-Associated Lymphoepithelioma-Like Gastric Carcinoma Located on Gastric High Body: Two Case Reports.

Primary lymphoepithelioma-like carcinoma of the lung. A clinicopathologic study of 11 cases

Primary lymphoepithelioma-like carcinoma of the lung: An unusual cancer and clinical outcomes of 14 patients

Surgical Treatment of Epstein-Barr Virus–associated Lymphoepithelioma-Like Carcinoma Occurring in Both the Posterior Mediastinum and Liver

Lymphoepithelioma-like carcinoma of the lung: a rare case report and review of the literature

Primary pulmonary lymphoepithelioma-like carcinoma: fifty-two patients with long-term follow-up.

Primary pulmonary lymphoepithelioma-like carcinoma: a rare type of lung cancer with a favorable outcome in comparison to squamous carcinoma

Analysis of 9 Cases of Primary Lymphoepithelioma-like Carcinoma of the Lung and Review of Literatures

Primary lymphoepithelioma-like carcinoma of the lung: distinct computed tomography features and associated clinical outcomes

P2.01-121 Genomic Profiling of Pulmonary Lymphoepithelioma-Like Carcinoma

Partial absence of PD-1 expression by tumor-infiltrating EBV-specific CD8+ T cells in EBV-driven lymphoepithelioma-like carcinoma

[Pulmonary lymphoepithelioma-like carcinoma with expression of Epstein-Barr virus and PD-L1]

Cliulcul Analysis of Primary Lymphoepithelioma-Like Carcinoma of the Lung

Pulmonary lymphoepithelioma-like carcinoma

Lymphoepithelioma-like Intrahepatic Cholangiocarcinoma with Epstein-Barr Virus Infection: Report of a Rare Case

Pulmonary lymphoepithelioma-like carcinoma: a Surveillance, Epidemiology, and End Results database analysis

Distinct Molecular Landscape of Epstein–Barr Virus Associated Pulmonary Lymphoepithelioma-Like Carcinoma Revealed by Genomic Sequencing

The Genomic Landscape of Epstein-Barr Virus-Associated Pulmonary Lymphoepithelioma-Like Carcinoma

Genomic Landscapes of Epstein-Barr Virus in Pulmonary Lymphoepithelioma-like Carcinoma

Lymphoepithelioma-like carcinoma of the lung: experience with ten cases